Home › Overweight › Florida › Orlando
Pag-aaral pangklinika para sa Overweight sa Orlando, FL
Isang pag-aaral para sa Overweight ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Orlando. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
Nagre-recruitPhase 2
- Charter Research - Winter Park /ID# 281968, Orlando
- Florida Institute For Clinical Research /ID# 282739, Orlando
Comparing the Efficacy and Safety of the EndoZip System and Apollo ESG in Obese Patients
Nagre-recruit
- Orlando Health, Inc., Orlando
A Study to Evaluate the Impact of Renal Impairment on the Pharmacokinetics (PK) of Ribupatide
Nagre-recruitPhase 1Malugod na tinatanggap ang malusog na boluntaryo
- Kailera Clinical Site, Orlando
AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight
Nagre-recruitPhase 3
- Florida Institute for Clinical Research, LLC, Orlando
Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes
Nagre-recruitPhase 2
- Clinical Site Partners, LLC DBA Flourish Research, Winter Park · 5 mi ang layo
- K2 Medical Research Maitland LLC, Main Office, Maitland · 6 mi ang layo
Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss
Nagre-recruitPhase 2
- Clinical Neuroscience Solutions, Orlando
AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight
Nagre-recruitPhase 3
- Clinical Neuroscience Solution, Orlando
- Florida Institute for Clinical Research, LLC, Orlando
A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide
Nagre-recruitPhase 3
- Florida Inst For Clin Res LLC, Orlando
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
Nagre-recruitPhase 3
- Headlands Research Orlando, Orlando
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
Nagre-recruitPhase 3
- Orlando Health, Orlando
- Digestive and Liver Center of Florida, Orlando
A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
Nagre-recruitPhase 3
- Florida Hospital- Center for Pediatric Research, Orlando
- Nemours Children's Health, Orlando
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
Nagre-recruitPhase 3
- Orlando Health, Orlando
- Digestive and Liver Center of Florida, Orlando
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
Nagre-recruitPhase 3
- Clinical Site Partners, LLC dba Flourish Research, Winter Park · 5 mi ang layo
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
Nagre-recruitPhase 3
- Research Site, Ocoee · 10 mi ang layo
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Nagre-recruitPhase 3
- West Orange Endocrinology, Ocoee · 10 mi ang layo
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
Nagre-recruitPhase 3
- Conquest Research, Winter Park · 5 mi ang layo
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
Nagre-recruitPhase 2
- Charter Research - Winter Park, Orlando
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
Nagre-recruitPhase 3
- AURORA-1 Clinical Site, Winter Park · 5 mi ang layo
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
Nagre-recruitPhase 3
- AURORA-2 Clinical Site, Winter Park · 5 mi ang layo
Feasibility and Acceptability of a Pediatric Referral to Summer Day Camps to Treat Obesity in Children From Low-Income Households
Nagre-recruit
- University of Central Florida, Orlando
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
Nagre-recruitPhase 3Malugod na tinatanggap ang malusog na boluntaryo
- ACCOMPLISH-2 Research Site, Ocoee · 10 mi ang layo
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
Nagre-recruitPhase 2
- Charter Research - Winter Park, Orlando
Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
Nagre-recruitPhase 3
- Kailera Clinical Site, Orlando
- Kailera Clinical Site, Orlando
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
Nagre-recruitPhase 3
- Clinical Neuroscience Solutions - Orlando, Orlando
- Combined Research Orlando Phase I IV, Orlando
- Florida Institute for Clinical Research, Orlando
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
Nagre-recruitPhase 3
- Florida Institute for Clinical Research, Orlando
- Conquest Research - Winter Park, Winter Park · 5 mi ang layo
Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
Nagre-recruitPhase 3
- Clinical Neuroscience Solutions, Orlando
- Florida Institute for Clinical Research, Orlando
Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
Nagre-recruitPhase 3
- ACCOMPLISH-1 Research Site, Ocoee · 10 mi ang layo
Pag-aaral para sa Overweight sa ibang lungsod
- San Antonio, TX34 pag-aaral
- Houston, TX33 pag-aaral
- Chicago, IL28 pag-aaral
- Las Vegas, NV23 pag-aaral
- Miami, FL23 pag-aaral
- Atlanta, GA20 pag-aaral
- Dallas, TX20 pag-aaral
- New York City, NY19 pag-aaral
- Jacksonville, FL19 pag-aaral
- Washington, DC19 pag-aaral
- Austin, TX18 pag-aaral
- Baltimore, MD17 pag-aaral
Iba pang pag-aaral sa Orlando
- Non-Small Cell Lung Cancer44 pag-aaral
- Obesity31 pag-aaral
- Metastatic Cancer29 pag-aaral
- Sakit ni Alzheimer25 pag-aaral
- Type 2 Diabetes24 pag-aaral
- Kanser (lahat ng uri)24 pag-aaral
- Kanser sa Suso23 pag-aaral
- Kanser sa Ovary22 pag-aaral
- Ulcerative Colitis22 pag-aaral
- Kanser sa Baga21 pag-aaral
- Colorectal Cancer19 pag-aaral
- Major Depressive Disorder19 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.